POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION
- 1 January 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8631), 188-191
- https://doi.org/10.1016/s0140-6736(89)91204-x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987
- Calcium Antagonizes 1,25-Dihydroxyvitamin D3Inhibition of Breast Cancer Cell Proliferation*Endocrinology, 1986
- 1,25-dihydroxyvitamin D3 inhibits the clonogenic growth of transformed cells via its receptorBiochemical and Biophysical Research Communications, 1986
- 1,25-Dihydroxyvitamin D3Binding in Estrogen-Responsive Rat Breast Tumor*Endocrinology, 1986
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984
- 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.Proceedings of the National Academy of Sciences, 1983
- Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences, 1981
- Current status of estrogen and progesterone receptors in breast cancerCancer, 1977
- Synthesis of 1alpha-hydroxy [6-3H]vitamin D3 and its metabolism to 1alpha, 25-dihydroxy [6-3H]vitamin D3 in the rat.Journal of Biological Chemistry, 1976